Teknova to Report First Quarter 2022 Financial Results on May 11, 2022
Alpha Teknova, Inc. (TKNO) will announce its Q1 financial results for the period ending March 31, 2022, on May 11, 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Alpha Teknova, Inc. (TKNO) will announce its Q1 financial results for the period ending March 31, 2022, on May 11, 2022. A conference call and webcast will occur at 4:30 p.m. ET the same day. The call can be accessed via the Investor Relations section of Teknova's website or by dialing dedicated numbers for domestic and international participants. Teknova specializes in providing critical reagents to support drug therapies, vaccines, and diagnostics, emphasizing customized products for accelerated clinical breakthroughs.
Positive
- Focus on agility and customization in life sciences
- Offers high-quality, made-to-order products
- Supports a wide range of applications including cell and gene therapy
Negative
- None.
Details
News Market Reaction – TKNO
The recorded move for TKNO in the trading session of this news was -2.56%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
HOLLISTER, Calif., May 04, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, development, and commercialization of drug therapies, novel vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the first quarter ended March 31, 2022, on Wednesday, May 11, 2022, following the close of market.
Teknova will host a webcast and conference call on Wednesday, May 11, 2022, beginning at 4:30 p.m. ET. Participants can access the live webcast on the Investor Relations section of the Teknova website and at this link: https://edge.media-server.com/mmc/p/6nk6u95b. The conference call can also be accessed by dialing +1 877-312-1451 for domestic callers and +1 470-495-9521 for international callers. The conference ID number is 7978825. The webcast will be available for replay on the Company’s website approximately two hours after the event.
About Teknova
Teknova is expediting clinical breakthroughs in life sciences by providing custom products and reagents for drug therapies, novel vaccines, and molecular diagnostics. With a focus on agility and customization, Teknova delivers research-grade and GMP products, including cell culture media and supplements, protein and nucleic acid purification buffers, and molecular biology reagents for a multitude of established and emerging applications, including cell and gene therapy, mRNA therapeutics, genomics, and synthetic biology. Teknova's proprietary processes enable the manufacture and delivery of high-quality, custom, made-to-order products with short turnaround times and at scale across all stages of development, including commercialization.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.